WARDWIZARD HEALTHCARE LIMITED

Services · Commercial Services & Supplies

BSE: 512063
₹18.00
May 6, 2009 · BSE · bse_bhavcopy
Quality
26/100
Weak
Valuation
—/100
Data unavailable
Momentum
—/100
Data unavailable

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹0 Cr
PE (TTM)
Data unavailable.
Price to Book
-0.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (372 companies)
EPS Growth (YoY)
-312.01%
as of June 30, 2026
Industry median 0.00% (300 companies)
Net Profit Growth (TTM)
-4.50%
as of June 30, 2026
Industry median 0.00% (325 companies)
Operating Revenue Growth (TTM)
166.07%
as of June 30, 2026
Industry median 0.00% (317 companies)
Profit Growth (YoY)
62.32%
as of Sept. 30, 2025
Industry median 2.13% (293 companies)
Revenue Growth (YoY)
237.11%
as of June 30, 2026
Industry median 7.61% (227 companies)
Current Ratio
0.19
as of March 31, 2026
Industry median 2.48 (345 companies)
Debt to Equity
-0.92
as of March 31, 2026
Industry median 0.06 (315 companies)
Interest Coverage
-34.39
as of June 30, 2026
Industry median 2.71 (293 companies)
Net Margin
-319.44%
as of Sept. 30, 2024
Industry median 3.80% (247 companies)
Operating Margin (EBIT)
-56.24%
as of June 30, 2026
Industry median 6.24% (257 companies)
Operating Margin (TTM)
-32.37%
as of June 30, 2026
Industry median 4.63% (310 companies)
Return on Assets
-123.07%
as of March 31, 2026
Industry median 0.99% (329 companies)
Return on Capital Employed
4.44%
as of March 31, 2026
Industry median 2.68% (300 companies)
Return on Equity
37.63%
as of March 31, 2026
Industry median 2.11% (328 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 5 met
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (-0.92)
  • Yes Return on equity is 15% or more (37.6%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 1 met
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
Data unavailable.
Low 18.0000 · High 18.0000
1W return
Data unavailable.
Low 18.0000 · High 18.0000
1M return
Data unavailable.
Low 18.0000 · High 18.0000
52W return
Data unavailable.
Low 18.0000 · High 18.0000
Lifetime High ₹18.0000 (May 6, 2009)
Lifetime Low ₹18.0000 (May 6, 2009)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish0

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

18.00
Pivot
First resistance18.00
Second resistance18.00
Third resistance18.00
First support18.00
Second support18.00
Third support18.00
Day RSI—
Day MFI—
Day MACD—
Day MACD signal—

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

—
Over 1 Month
LowHigh
18.0018.00
—
Over 3 Months
LowHigh
18.0018.00
—
Over 6 Months
LowHigh
18.0018.00
—
Over 1 Year
LowHigh
18.0018.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹1 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹-18.0000

Ranks #308 of 315 in Commercial Services & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter74.08%

Largest holders

NameCategoryShares %Shares
YATIN SANJAY GUPTEPromoter37.0400%90750
SHEETAL MANDAR BHALERAOPromoter14.1900%34760
WARDWIZARD SOLUTIONS INDIA PRIVATE LIMITEDPromoter11.4500%28058
WARDWIZARD MEDICARE PRIVATE LIMITEDPromoter11.4000%27932
SHIKESH VENTURES PRIVATE LIMITEDPublic4.9000%12000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 74.08% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
17 Jun 2025 SHIVA AVDHESHRATAN DUBEY Bulk Sell 3,200 22.9600 BSE
17 Jun 2025 RUCHIRA GOYAL Bulk Buy 3,200 22.9600 BSE
17 Oct 2024 AALEKH PRAKASH SHAH Bulk Sell 2,000 18.9000 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Ayoki Mercantile Ltd. to WARDWIZARD HEALTHCARE LIMITED

All corporate actions →

Corporate Announcements

All 6 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Wardwizard Healthcare Ltd - 512063 - Shareholder Meeting / Postal Ballot-Outcome of AGM
19 Sep 2026 AGM/EGM Wardwizard Healthcare Ltd - 512063 - CORRIGENDUM TO NOTICE OF 42ND ANNUAL GENERAL MEETING
5 Sep 2026 AGM/EGM Wardwizard Healthcare Ltd - 512063 - Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants
5 Sep 2026 AGM/EGM Wardwizard Healthcare Ltd - 512063 - Submission Of Notice Of 42Nd Annual General Meeting (AGM) For The Financial Year 2025-26.
5 Sep 2026 Corp. Action Wardwizard Healthcare Ltd - 512063 - Intimation For Book Closure Date & Cut Off Date For The Purpose Of 42Nd Annual General Meeting For The Financial Year 2025-26.
5 Sep 2026 Others Wardwizard Healthcare Ltd - 512063 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (37.6%)
  • Strong revenue growth YoY (237.1%)

Weaknesses

  • Thin net profit margin (-319.4%)
  • Negative shareholder equity (Debt/Equity -0.92) -- accumulated losses exceed paid-in capital
  • Tight liquidity (Current Ratio 0.19)

Opportunities

Data unavailable.

Threats

  • Weak interest coverage (-34.4x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about WARDWIZARD HEALTHCARE LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.